How the proteins in our bodies bind together to form protein complexes plays a critical role in numerous cell functions—staving off diseases, for instance, or transporting ions across cell membranes.
The company said on Friday night that the federal government had ordered limits on its Mythos and Fable 5 A.I. systems, citing national security concerns. By Cade Metz and Dustin Volz Cade Metz ...
The Trump administration is banning foreign governments, companies and individuals from using Anthropic’s most powerful artificial-intelligence tools, prompting the company to shut off access to ...
AI company Anthropic has disabled customer access to its most capable systems after the US government ordered it to suspend all use by foreign nationals, Anthropic said in a statement Friday evening.
June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's (SASY.PA), opens new tab type 1 diabetes injection in children aged 8 to ‌17 years ...
ImmunityBio receives good news all around – the U.S. Food and Drug Administration has accepted for review the company’s application for expanded use of Anktiva and it acquired a strain of a related ...
Johnson & Johnson (JNJ) reported new clinical trial results showing that its experimental subcutaneous formulation of amivantamab produced durable responses in patients with advanced head and neck ...
The Associated Press today released the 58th edition of The Associated Press Stylebook, the must-have reference for writers, editors, students and professionals. It is the definitive resource for ...
Not even a week into the WNBA season, several teams are already shorthanded—and a couple have already secured salary cap hardship exceptions. Both the Liberty and Valkyries received emergency hardship ...
New pickleball and basketball courts, a dog park and a service dog park, and an area with exercise equipment are among the new amenities for students being installed in the area of the south lawn of ...
The U.S. Food and Drug Administration has green-lit the first-ever non-antipsychotic drug treatment for agitation in Alzheimer’s disease patients. The drug, Auvelity, was originally FDA-approved in ...